iAnthus Capital Holdings (FRA:2IA) Shares Outstanding (EOP): 6,972.6 Mil (As of Mar. 2026)


What is iAnthus Capital Holdings Shares Outstanding (EOP)?

iAnthus Capital Holdings FRA:2IA Shares Outstanding (EOP) is 6,972.6 Mil as of Mar. 2026. The stock has 4 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. iAnthus Capital Holdings's shares outstanding for the quarter that ended in Mar. 2026 was 6,972.6 Mil.

iAnthus Capital Holdings's quarterly shares outstanding increased from Dec. 2025 (6,859.1 Mil) to Mar. 2026 (6,972.6 Mil). It means iAnthus Capital Holdings issued new shares from Dec. 2025 to Mar. 2026 .

iAnthus Capital Holdings's annual shares outstanding increased from Dec. 2024 (6,678.4 Mil) to Dec. 2025 (6,859.1 Mil). It means iAnthus Capital Holdings issued new shares from Dec. 2024 to Dec. 2025 .


iAnthus Capital Holdings  (FRA:2IA) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


iAnthus Capital Holdings Shares Outstanding (EOP) Related Terms


iAnthus Capital Holdings Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for iAnthus Capital Holdings's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iAnthus Capital Holdings Shares Outstanding (EOP) Chart

iAnthus Capital Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 171.72 6,403.29 6,510.53 6,678.40 6,859.13

iAnthus Capital Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,745.69 6,735.93 6,817.46 6,859.13 6,972.55

FRA:2IA vs ZTS, UTHR: Shares Outstanding (EOP) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, iAnthus Capital Holdings's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iAnthus Capital Holdings Shares Outstanding (EOP) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, iAnthus Capital Holdings's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where iAnthus Capital Holdings's Shares Outstanding (EOP) falls into.



iAnthus Capital Holdings Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 6,972.6 Mil mean?
iAnthus Capital Holdings (FRA:2IA) has a Shares Outstanding (EOP) of 6,972.6 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on iAnthus Capital Holdings and its competitors.
Is iAnthus Capital Holdings' Shares Outstanding (EOP) too high?
iAnthus Capital Holdings' current Shares Outstanding (EOP) is 6,972.6 Mil.
How does iAnthus Capital Holdings' Shares Outstanding (EOP) compare to ZTS and UTHR?
iAnthus Capital Holdings' Shares Outstanding (EOP) of 6,972.6 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Drug Manufacturers company?
A good Shares Outstanding (EOP) depends on the Drug Manufacturers industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on iAnthus Capital Holdings and its competitors. iAnthus Capital Holdings's current Shares Outstanding (EOP) is 6,972.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iAnthus Capital Holdings stock overvalued right now?
iAnthus Capital Holdings (FRA:2IA) has a current Shares Outstanding (EOP) of 6,972.6 Mil. The current Shares Outstanding (EOP) is 6,972.6 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For iAnthus Capital Holdings (FRA:2IA), the current Shares Outstanding (EOP) is 6,972.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

iAnthus Capital Holdings Business Description

Other Exchanges ITHUF:USAIAN:Canada
Address 214 King Street West, Suite 314, Toronto, ON, CAN, M5H 3S6
iAnthus Capital Holdings Inc is a vertically-integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities and a developer, producer, and distributor of branded cannabis products in the United States. Its Cannabis product offerings include flower and trim, products containing cannabis flower and trim (such as packaged flower and pre-rolls), cannabis infused products (such as topical creams and edibles), and products containing cannabis extracts (such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures). The company's reportable operating segments are the Eastern Region, which generates the maximum revenue, and the Western Region.